Maravai LifeSciences/MRVI

$8.36

64.38%
-
1D1W1MYTD1YMAX

About Maravai LifeSciences

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The Company’s segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of modified nucleic acid products to support the needs of customers’ research, therapeutic and vaccine programs. This segment also provides research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. It provides products that support its customers’ needs from discovery through commercialization of their vaccines, therapeutic agents and in vitro diagnostic products.
Ticker
MRVI
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
Carl Hull
Employees
670
Headquarters
San diego, United States

MRVI Metrics

BasicAdvanced
$2.1B
Market cap
-
P/E ratio
-$0.90
EPS
-
Beta
-
Dividend rate

What the Analysts think about MRVI

Analyst Ratings

Majority rating from 12 analysts.
Buy

Price Targets

Average projection from 10 analysts.
9.57% upside
High $14.00
Low $6.50
$8.36
Current price
$9.16
Average price target

MRVI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-142.91% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$74.1M
10.93%
Net income
$-105.9M
1,554.69%
Profit margin
-142.91%
1,391.75%

MRVI Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 257.13%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q1 24
Actual
$0.03
-
-$0.01
-
Expected
$0.04
$0.01
$0.01
-$0.00
Surprise
-17.24%
-
-257.13%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Maravai LifeSciences stock

Buy or sell Maravai LifeSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing